Apple (NasdaqGS:AAPL) Gains FDA Approval for OTC Hearing Aid, Boosting Innovation and Market Potential

Apple is experiencing growth and challenges, with a record revenue of $85.8 billion but declining iPhone sales. Despite some weaknesses like a high Price-To-Earnings Ratio, the company's investments in AI and new products present opportunities for future growth.